Trial Profile
A Randomized Controlled Trial of Methylphenidate Transdermal System (Daytrana), Lisdexamfetamine Dimesylate (Vyvanse), OROS MPH (Concerta), and Mixed Amphetamine Salts Extended Release (Adderall XR) in Children and Adolescents With ADHD.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2015
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary) ; Methylphenidate (Primary) ; Methylphenidate; Mixed amfetamine salts
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms NOTA
- 28 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2012 Planned End Date changed from 1 Dec 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 18 Apr 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.